¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-µÑ°³¯ : 2024-05-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-µÑ°³¯ : 2024-05-17
±³À°ÀÏÀÚ : 2024-05-17
±³À°Àå¼Ò : ÄÜ·¡µå ¼­¿ï

±³À°ÁÖÁ¦ : (¿Â.¿ÀÇÁ º´Çà) 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-µÑ°³¯

ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630  

À̸ÞÀÏ : webmaster@rheum.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í »çÀüµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 180,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 230,000¿ø ÇöÀåµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 200,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 250,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 08:00~08:40 Optimizing Patient Care in Axial Spondyloarthritis ÀÌÁÖÇÏ(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 09:00~10:00 Navigating the Expansive Landscape of Future Therapy in Rheumatoid Arthritis Daniel Aletaha(Medical Univ. of Vienna, Austria)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 10:30~11:00 Infectious Complications during Targeted Therapy for Rheumatic Diseases Masayoshi Harigai(Tokyo Women¡¯s Medical Univ., Japan)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 11:00~11:30 H. zoster Infection in Rheumatic Disease Jeffrey R Curtis(The Univ. of Alabama at Birmingham, USA)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 11:30~12:00 Pneumocystis Pneumonia in Rheumatic Disease: A Focus on Prophylaxis Strategies ¹ÚÁØ¿ø(¼­¿ï´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 12:00~12:40 What We Have Learned and What We Need Find Out from TNF Inhibition for Chronic ÀÌÀº¿µ(¼­¿ï´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 13:00~13:30 Integrating symptom tracking into clinical care William Dixon(Manchester Univ. UK)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 13:30~14:00 How to incorporate rheumatoid arthritis specialized telemedicine enabled by IoT and AI Atsushi Kawakami(Nagasaki Univ., Japan)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 14:00~14:30 Digital health strategies to optimize clinical research and care in rheumatology Jeffrey R Curtis(Univ. of Alabama, USA)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:30~15:40 (±¸¿¬ ¹ßÇ¥) Clinical relevance of the systemic lupus erythematosus disease activity score (SLE-DAS) in predicting lupus outcomes: A 5-year longitudinal cohort study °­ÁöÇå(Àü³²´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:40~15:50 (±¸¿¬ ¹ßÇ¥) Monitoring disease activity and treatment response in Korean patients with systemic lupus ±èÁö¿ø (¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:50~16:00 (±¸¿¬ ¹ßÇ¥) Elevated risk of bacterial meningitis in systemic lupus erythematosus patients and investigation of risk factors in Taiwan: A nationwide population-based study Han Cheng (Immunology and Allergy, Tri-Service General Hosp., Nat)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:00~16:10 (±¸¿¬ ¹ßÇ¥) Antiphospholipid syndrome in pediatric lupus- clinico- laboratory manifestation and long term follow up - a 25 years experience from Northwest India Abarna Thangaraj(Advance Pediatric Centre, PGIMER, Chandigarh, India)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:10~16:20 (±¸¿¬ ¹ßÇ¥) Hyperuricemia as a prognostic marker for antiphospholipid syndrome: a cohort study of Chinese patients Liang Luo(The People)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:30~16:40 (±¸¿¬ ¹ßÇ¥) Predictors of renal function preservation in non-responders to induction therapy for proliferative lupus nephritis ±è¿µÀº(¿ï»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:40~16:50 (±¸¿¬ ¹ßÇ¥) Lupus flare and recurrent lupus nephritis following kidney transplantation in patients with lupus nephritis ±è¿µÀº(¿ï»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:50~17:00 (±¸¿¬ ¹ßÇ¥) Long-term outcomes of male patients with lupus nephritis compared with female patients ÀüÈ£¿í(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 17:00~17:10 (±¸¿¬ ¹ßÇ¥) Effect of renin-angiotensin-system inhibitors on renal remission in lupus nephritis: A real-world study Xiaohui Zhang (Peking Univ. First Hospital, China)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 17:10~17:20 (±¸¿¬ ¹ßÇ¥) Unveiling a novel trend: Belimumab amplifies retinal microvascular density decline in lupus nephritis patients revealed by optical coherence tomography angiography Maierhaba Maitiyaer (The Second Affiliated Hosp. of Guangzhou Medical Univ., Guangzhou, Guangdong, China)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 08:00~08:40 A Well-balanced JAKi from Efficacy and Safety Perspectives. ¼Ò¹Î¿í(ºÎ»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Difficult-to-treat rheumatoid arthritis among elderly RA from the KOBIO registry Á¤ÁÖ¾ç(¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 10:40~10:50 (±¸¿¬ ¹ßÇ¥) Validation of Boolean 2.0 criteria for assessing remission and predicting quality of life in Korean Patients with Rheumatoid Arthritis Undergoing Targeted Therapy Á¶¼ö°æ(ÇѾç´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 10:50~11:00 (±¸¿¬ ¹ßÇ¥) The predictive accuracy of EULAR defined clinically suspected arthralgia for the development of rheumatoid arthritis: a prospective longitudinal study Cheuk Yin Tam(The Chinese Univ. of Hong Kong, Hong Kong)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Exploring risk factors for adverse events and infections in RA and RA with ILD under treatment with biologics or targeted synthetic DMARDs: findings from the KOBIO registry ±èÁö¿ø(¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:10~11:20 (±¸¿¬ ¹ßÇ¥) Comprehensive analysis of patients with rheumatoid arthritis with interstitial lung disease: Clinical characteristics, treatment patterns, and prognostic factors ±èÁö¿ø(¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:20~11:30 (±¸¿¬ ¹ßÇ¥) Risk of anti-rheumatic agents on stroke risk in rheumatoid arthritis: A Korean nationwide case-control study ¾È¼ö¹Î(¿ï»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:30~11:40 (±¸¿¬ ¹ßÇ¥) Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis ¹ÚÀºÇý(Áß¾Ó´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:40~11:50 (±¸¿¬ ¹ßÇ¥) Early-life environmental influences on rheumatoid arthritis risk: Insights from a large retrospective study in Chinese adults Liang Luo(Peking Univ., People)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Impact of glucocorticoids on the therapeutic efficacy of denosumab in osteoporosis of rheumatoid arthritis patients ¾çÁö¿ø(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 12:00~12:40 Treatment Journey to Protect Bone Fractures È«¼®Âù(¿ï»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 13:00~13:30 Basics of Bone Biology to Understand Osteoporosis Medications ±è¹üÁØ(¿ï»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 13:30~14:00 Real World Evidence of Anabolic Therapy in PMO ±èÇÏ¿µ(¿ï»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 14:00~14:30 Anabolic Treatment for GIOP ¼­Ã¢Èñ(¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 15:30~16:30 Ethical Issues in Clinical Research and Publication È«¼ºÅÂ(¼­¿ï´ëÇб³) Çʼö

±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 16:30~17:30 Prevention and Control of Healthcare-associated Infections ÇãÁö¾È(¿µ³²´ëÇб³) Çʼö

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 08:00~08:40 What Distinguishes Secukinumab as an Optimal Choice in AS? ¾È¼º¼ö(¿¬¼¼´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Association between metabolic marker and knee osteoarthritis: A cross-sectional study using the Korea National Health And Nutrition Examination survey 2009 to 2013 ÃÖÇöÁØ(µ¿¾Æ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 10:40~10:50 (±¸¿¬ ¹ßÇ¥) Psychotropic drug use in Korean patients with osteoarthritis ±èÇö¾Æ(ÇѸ²´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 10:50~11:00 (±¸¿¬ ¹ßÇ¥) Comparative effectiveness of yoga and strengthening exercise for treating knee osteoArthritis: A randomised controlled trial (yoga trial) Benny Samuel Eathakkattu Antony(Menzies Institute for Medical Research, Univ. of Tasmania, Australia)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Vitamin D deficiency is associated with progression of radiographic hand osteoarthritis in a 6-year follow-up of the Dong-gu study ÃÖ¼ºÀº(Àü³²´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:20~11:30 (±¸¿¬ ¹ßÇ¥) GelMA hydrogel microspheres integrating fullerenol and extracellular vesicles alleviate osteoarthritis Tianqi Wang(Yong Loo Lin School of Medicine, National Univ. of Singapore, Singapore)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:30~11:40 (±¸¿¬ ¹ßÇ¥) MSC exosomes alleviate osteoarthritis by inhibiting complement activation via CD59-dependent pathway Kristeen Ye Wen Teo(Nat)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:40~11:50 (±¸¿¬ ¹ßÇ¥) The interplay between endoplasmic reticulum stress and oxidative stress in chondrocyte catabolism ÇÑÁø(°æºÏ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Therapeutic efficacy and safety of intra articular injection of human bone marrow derived mesenchymal stem cells in cnee osteoarthritis; randomized, double-blind, placebo-controlled clinical trial À̺À¿ì(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 12:00~12:40 Treatment Strategies for Improving Patient-specific Care with SIMPONI IV ÀÌ»óÈÆ(°æÈñ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:00~13:10 (±¸¿¬ ¹ßÇ¥) The long-term outcome of renal involvement in primary Sjogren¡¯s syndrome: A possible association with lymphoproliferative disease °íÁ¤Èñ(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:10~13:20 (±¸¿¬ ¹ßÇ¥) The risk of heart diseases in offspring born to mothers with primary Sjögren Yingbo Zhou(The First Affiliated Hosp. of Univ. of Science and Technology of China, China)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:20~13:30 (±¸¿¬ ¹ßÇ¥) Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity and lymphoma risk factors in primary Sjögren ¾çÁö¿ø(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:30~13:40 (±¸¿¬ ¹ßÇ¥) Measurement of serum cytokine and chemokine level to predict poor treatment response in patients with inflammatory myositis Á¶¼ºÀÍ(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:40~13:50 (±¸¿¬ ¹ßÇ¥) Clinical features and treatment strategies associated with relapses of IgG4-related disease: A retrospective multicenter study ¼ÕÇÏÈñ(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:50~14:00 (±¸¿¬ ¹ßÇ¥) The risk of stroke and myocardial infarction in systemic sclerosis: A population-based study Àº¿µÈñ(¼º±Õ°ü´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 14:00~14:10 (±¸¿¬ ¹ßÇ¥) A glimpse of MRI deep white mater hyperintensities in systemic sclerosis patients Shihan Xu(Peking Union Medical College Hosp., China)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 14:10~14:20 (±¸¿¬ ¹ßÇ¥) Association of vitamin D levels in systemic sclerosis patients: A meta-analysis °­Àº¼Û (°í·Á´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 15:30~15:40 (±¸¿¬ ¹ßÇ¥) Mind-body interventions in the management of fibromyalgia: Effects on pain perception, psychological well-being, and quality of life Sahnaz Vivinda Putri(International Univ. Semen Indonesia, Indonesia)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 15:40~15:50 (±¸¿¬ ¹ßÇ¥) Study of quality of life, metabolic and oxidative stress biomarkers In fibromyalgia patients Pardeep Kumar(Biochemistry, F H Medical College & Hosp., India)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 15:50~16:00 (±¸¿¬ ¹ßÇ¥) Exploring arthritis risk factors and their association with metabolic syndrome in Indonesia: Insights from the Indonesia family life study Nadyatul Husna (Alumnus of Universitas Andalas, Indonesia)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:00~16:10 (±¸¿¬ ¹ßÇ¥) To characterise cases of de novo check point inhibitor (CPI) induced polyarthritis in cancer patients treated at a tertiary referral centre Jang Yoon(Westmead Hosp., Australia)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:30~16:40 (±¸¿¬ ¹ßÇ¥) Human nasal turbinate-derived stem cells with specific gene signatures (HAS2, CXCL1, KRTAP1-5, GSTT2B, and C4B) attenuate rheumatoid arthritis ¹ÎÈ«±â (°Ç±¹´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:40~16:50 (±¸¿¬ ¹ßÇ¥) Ganoderic acid ameliorate complete freund adjuvant induced arthritis rats via suppression of HIF-1¥á–VEGF–ANG-1 axis Vikas Kumar(Pharmaceutical Sciences, SAM HIGGINBOTTOM Univ. OF AGRICULTURE, TECHNOLOGY & SCIENCES, India)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:50~17:00 (±¸¿¬ ¹ßÇ¥) Cyr61 activates mitochondrial autophagy and regulated the phenotype transformation of rheumatoid arthritis fibroblast-like synoviocytes via the ROS/Hif-1¥á/BNIP3 pathway Yanni Gui(Peking Univ. First Hosp., China)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 17:00~17:10 (±¸¿¬ ¹ßÇ¥) Differential gender effect on rheumatoid arthritis-associated interstitial lung disease and potential steroid hormone mechanisms in SKG mice ±è¹Ì¼Û(°æÈñ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 17:10~17:20 (±¸¿¬ ¹ßÇ¥) Swimming exercise improves muscle strength and modulates irisin expression to alleviates joint and gut inflammation in curdlan-injected SKG mice Á¶¼º½Å(¼øõÇâ´ëÇб³)

±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 17:20~17:30 (±¸¿¬ ¹ßÇ¥) A genome wide association study on ankylosing spondylitis in Koreans identified new susceptibility loci ±¸º»»ê(ÀÎÁ¦´ëÇб³)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-µÑ°³¯ : 2024-05-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Ç÷°üÁßÀç½Ã¼ú¿¬±¸È¸ 2024 K-VIS(Korea Vascular Intervention Society) Annual Symposium : 2024-05-17
´ÙÀ½±Û Á¦54Â÷ ´ëÇѼҾƳ»ºÐºñÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 28 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 26 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 31 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 32 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 28 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 20 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 8 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 16 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 6 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 19 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 11 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 19 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 13 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷